Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026)
Hims & Hers Health (HIMS) posted Shares Outstanding (Entity) of $230.7 million for Q1 2026, up 1.52% sequentially from $227.2 million in Q4 2025, and up 3.18% YoY from $223.6 million in Q1 2025.
Hims & Hers Health (HIMS) Shares Outstanding (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Shares Outstanding (Entity) for 8 years, with the latest figure at $230.7 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 3.18% year-over-year to $230.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $230.7 million (up 3.18% YoY) and the FY2025 annual result came in at $227.2 million, up 2.9% from the prior year.
- Shares Outstanding (Entity) climbed to $230.7 million in Q1 2026 per HIMS's latest filing, from $227.2 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $230.7 million in Q1 2026 and troughed at $205.9 million in Q1 2022.
- A 5-year average of $216.4 million and a median of $214.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 34.49% in 2022, then increased 1.67% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $208.4 million in 2022, then increased by 2.42% to $213.5 million in 2023, then rose by 3.45% to $220.8 million in 2024, then climbed by 2.9% to $227.2 million in 2025, then increased by 1.52% to $230.7 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $230.7 million, $227.2 million, and $227.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 231.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231.75 Mn |
| Mar 31, 2026 | 228.36 Mn |
| Dec 31, 2025 | 224.96 Mn |
| Sep 30, 2025 | 226.35 Mn |
| Jun 30, 2025 | 224.37 Mn |
| Mar 31, 2025 | 221.99 Mn |
| Dec 31, 2024 | 215.94 Mn |
| Sep 30, 2024 | 216.62 Mn |
| Jun 30, 2024 | 214.62 Mn |
| Mar 31, 2024 | 213.45 Mn |
| Dec 31, 2023 | 209.34 Mn |
| Sep 30, 2023 | 210.13 Mn |
| Jun 30, 2023 | 208.42 Mn |
| Mar 31, 2023 | 207.14 Mn |
| Dec 31, 2022 | 204.52 Mn |
| Sep 30, 2022 | 205.23 Mn |
| Jun 30, 2022 | 203.95 Mn |
| Mar 31, 2022 | 202.70 Mn |
| Dec 31, 2021 | 186.78 Mn |
| Sep 30, 2021 | 200.04 Mn |